Private company
Clever Leaves Holdings Inc.
Canadian pharmaceutical preparations company, incorporated in British Columbia1
In its 2024 annual report the company says: “We are a multi-national operator in the botanical cannabinoid and nutraceutical industries, with operations and investments in Colombia, the United States, and Canada. We are working to develop one of the industry’s leading, low-cost global supply chains with the goal of providing high quality, pharmaceutical grade cannabis and wellness products to customers and patients at competitive prices produced in a sustainable and environmentally friendly manner.”4
Last updated Oct 21, 2026.
Overview
- IndustryPharmaceutical Preparations1
- HeadquartersA11
- Incorporated inBritish Columbia, Canada2
- Business addressBodega 19-B Parque Industrial Tibitoc Ph, Tocancipa - Cundinamarca, F8 2510172
- Filer categoryNon-accelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
Our mission is to innovate in cannabis products and services, from raw materials to finished products, in an environmentally friendly manner and to be an industry-leading global cannabinoid company recognized for our principles, people, and performance while fostering a healthier global community.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue62¢$10.9M
- Research and development7¢$1.1M
- Other costs31¢$5.3M
- Income tax0¢$68.0K
Out of $17.4M in revenue.5 The company lost money this year.
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenue | $7.8M6 | $12.1M7 | $15.4M8 | $16.4M5 | $17.4M5 | |
| Cost of revenue | $4.7M6 | $4.7M7 | $8.6M8 | $9.2M5 | $10.9M5 | |
| Gross profit | $3.1M6 | $7.4M7 | $6.8M8 | $7.2M5 | $6.6M5 | |
| Research and development | $1.0M7 | $1.5M8 | $1.7M5 | $1.1M5 | ||
| Operating expenses | $64.0M8 | $54.1M5 | $22.1M5 | |||
| Operating income | -$36.5M6 | -$28.5M7 | -$57.2M8 | -$46.9M5 | -$15.6M5 | |
| Income before tax | -$44.7M8 | -$44.1M5 | -$19.7M5 | |||
| Income tax | $06 | $07 | $950.0K8 | -$6.4M5 | $68.0K5 | |
| Net income | -$39.5M6 | -$25.9M7 | -$45.7M8 | -$66.2M5 | -$17.9M5 | |
| Earnings per share | -$3.347 | -$1.788 | -$51.705 | -$11.425 | ||
| Earnings per share (diluted) | -$3.347 | -$1.788 | -$51.705 | -$11.425 | ||
| Shares (weighted, basic) | 25.7M shares8 | 1.3M shares5 | 1.6M shares5 | |||
| Shares (weighted, diluted) | 25.7M shares8 | 1.3M shares5 | 1.6M shares5 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Cash | $21.3M6 | $12.0M6 | $79.1M7 | $37.2M8 | $12.4M5 | $6.8M5 |
| Receivables | $2.2M8 | $2.3M5 | $907.0K5 | |||
| Inventory | $15.4M8 | $8.4M5 | $4.5M5 | |||
| Current assets | $23.5M6 | $95.8M7 | $60.4M8 | $26.2M5 | $13.9M5 | |
| Property, plant and equipment | $30.9M8 | $14.0M5 | $12.3M5 | |||
| Goodwill | $08 | $08 | ||||
| Intangible assets | $23.1M8 | $3.4M5 | $2.7M5 | |||
| Total assets | $95.7M6 | $165.9M7 | $116.2M8 | $52.1M5 | $31.2M5 | |
| Accounts payable | $4.0M8 | $2.3M5 | $2.1M5 | |||
| Short-term debt | $17.5M8 | $465.0K8 | ||||
| Current liabilities | $6.1M6 | $30.1M7 | $27.2M8 | $9.4M5 | $5.8M5 | |
| Long-term debt | $33.7M6 | $33.0M7 | $7.6M8 | $1.1M8 | $1.2M5 | |
| Total liabilities | $45.5M6 | $70.6M7 | $43.4M8 | $11.7M5 | $7.0M5 | |
| Retained earnings | -$114.7M8 | -$180.9M5 | -$198.8M5 | |||
| Shareholders’ equity | $42.6M6 | $50.2M7 | $95.2M8 | $72.8M5 | $40.4M5 | $24.2M5 |
| Shares outstanding | 8.3M shares6 | 24.9M shares7 | 26.6M shares8 | 1.5M shares5 | 1.7M shares5 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Cash from operations | -$37.1M6 | -$22.0M7 | -$36.2M8 | -$29.1M5 | -$11.5M5 | |
| Depreciation and amortization | $1.8M8 | $1.2M5 | $981.0K5 | |||
| Stock-based compensation | $11.5M8 | $2.3M5 | $818.0K5 | |||
| Capital spending | $18.7M6 | $3.7M7 | $7.3M8 | $1.3M5 | $31.0K5 | |
| Free cash flow | -$55.7M | -$25.6M | -$43.5M | -$30.4M | -$11.5M | |
| Cash from investing | -$7.3M8 | $1.2M5 | $4.7M5 | |||
| Share buybacks | $6.2M7 | $07 | ||||
| Cash from financing | $1.8M8 | $3.3M5 | $656.0K5 |
Corporate structure
Clever Leaves Holdings Inc. sits at the top of its group. 20 entities, 7 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Clever Leaves Holdings Inc.
- BCM Investimentos Fundo de Investimento Multimercado Credito Privado Investimento no Exterior Filed SC 13D/A on Clever Leaves Holdings Inc., latest May 21, 2024 (2 filings since May 15, 2024)
- FARALLON CAPITAL MANAGEMENT, L.L.C. Filed SC 13G/A on Clever Leaves Holdings Inc., latest Jan 23, 2024 (3 filings since Feb 14, 2022)
- Kyle Detwiler Filed SC 13D/A on Clever Leaves Holdings Inc., latest May 23, 2023
- Schultze Special Purpose Acquisition Sponsor, LLC Filed SC 13D/A on Clever Leaves Holdings Inc., latest Apr 3, 2023 (2 filings since Feb 7, 2022)
- ETF MANAGERS GROUP, LLC Filed SC 13G/A on Clever Leaves Holdings Inc., latest Feb 14, 2022 (2 filings since Nov 16, 2021)
- Clever Leaves Holdings Inc. A1
- 1255096 B.C. Ltd. ("Newco") Subsidiary · British Columbia, Canada
- Clever Leaves Australia Pvt Ltd Subsidiary · Australia
- Clever Leaves Germany GmbH Subsidiary · Germany
- Clever Leaves II Portugal Cultivation SA Subsidiary · Portugal
- Clever Leaves International, Inc. Subsidiary · British Columbia, Canada
- Clever Leaves Portugal Unipessoal LDA Subsidiary · Portugal
- Clever Leaves UK Limited Subsidiary · United Kingdom
- Clever Leaves US, Inc. ("SAMA") Subsidiary · Delaware, United States
- Eagle Canada Holdings, Inc. (“Eagle Canada”) Subsidiary · British Columbia, Canada
- Ecomedics S.A.S. (“Ecomedics”) Subsidiary · Colombia
- Herbal Brands, Inc. Subsidiary · Delaware, United States
- Nordschwan Holdings, Inc. Subsidiary · British Columbia, Canada
- Northern Swan Deutschland Holdings, Inc. Subsidiary · British Columbia, Canada
- Northern Swan Europe, Inc. Subsidiary · British Columbia, Canada
- Northern Swan International, Inc. (“NSI”) Subsidiary · British Columbia, Canada
- Northern Swan Management, Inc. Subsidiary · British Columbia, Canada
- Northern Swan Portugal Holdings, Inc. Subsidiary · British Columbia, Canada
- NS Herbal Brands International, Inc. Subsidiary · British Columbia, Canada
- NS US Holdings, Inc. Subsidiary · Delaware, United States
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Clever Leaves Holdings Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $21.1M5 Dec 31, 2023 | $21.1M5 Dec 31, 2022 | +0.1% |
| Accumulated depreciation | $8.8M5 Dec 31, 2023 | $7.1M5 Dec 31, 2022 | +23.5% |
| Property and equipment, net | $12.3M5 Dec 31, 2023 | $14.0M5 Dec 31, 2022 | −11.8% |
| Operating-lease assets (leased space) | $829.0K5 Dec 31, 2023 | $1.3M5 Dec 31, 2022 | −36.4% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $6.8M5 Dec 31, 2023 | $12.4M5 Dec 31, 2022 | −45.1% |
| Stakes in other companies (equity method) | $05 Dec 31, 2023 | $5.7M5 Dec 31, 2022 | −100.0% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $08 Dec 31, 2022 | $08 Dec 31, 2021 | |
| Intangible assets, net (excluding goodwill) | $2.7M5 Dec 31, 2023 | $3.4M5 Dec 31, 2022 | −20.9% |
| Indefinite-lived intangibles (excluding goodwill) | $05 Dec 31, 2022 | $19.0M8 Dec 31, 2021 | −100.0% |
| Finite-lived intangibles, gross | $7.1M5 Dec 31, 2023 | $7.1M5 Dec 31, 2022 | 0% |
| Accumulated amortization | $4.4M5 Dec 31, 2023 | $3.7M5 Dec 31, 2022 | +18.8% |
| Finite-lived intangibles, net | $2.7M5 Dec 31, 2023 | $3.4M5 Dec 31, 2022 | −20.9% |
Inventory
Leadership
Who has led Clever Leaves Holdings Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerAndres Fajardo Jul 6, 2022 to Jan 23, 202411
- Chief executive officerKyle Detwiler Dec 18, 2020 to Jan 18, 202212
- PresidentAndres Fajardo Dec 18, 2020 to Jan 18, 202213
- Chief financial officerHenry R. Hague Iii. Feb 22, 2021 to Mar 12, 202414
- Chief financial officerAmit Pandey Dec 18, 2020 to Dec 22, 202015
Board members and other officers (9)
- Chief Regulatory OfficerJulian Wilches Dec 18, 2020 to Jan 23, 202416
- Board memberGeorge J. Schultze Feb 3, 2022 to Jun 27, 202317
- Board memberWilliam Muecke Mar 25, 2022 to Jun 30, 202318
- Board memberAndres Fajardo Dec 18, 2020 to Jan 23, 202413
- Board memberElisabeth H. Demarse Dec 18, 2020 to Jun 27, 202319
- Board memberEtienne H. Deffarges Dec 18, 2020 to Jun 30, 202120
- Board memberGary M. Julien Dec 18, 2020 to Jun 30, 202321
- Board memberKyle Detwiler Dec 18, 2020 to Jan 18, 202212
- General counselDavid Kastin Jun 4, 2021 to Jul 6, 202222
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- 1255096 B.C. Ltd. ("Newco") British Columbia, Canada3
- Clever Leaves Australia Pvt Ltd Australia3
- Clever Leaves Germany GmbH Hamburg, Germany3
- Clever Leaves II Portugal Cultivation SA Portugal3
- Clever Leaves International, Inc. British Columbia, Canada3
- Clever Leaves Portugal Unipessoal LDA Portugal3
- Clever Leaves UK Limited London, United Kingdom3
- Clever Leaves US, Inc. ("SAMA") Delaware, United States3
- Eagle Canada Holdings, Inc. (“Eagle Canada”) British Columbia, Canada3
- Ecomedics S.A.S. (“Ecomedics”) Bogota, Colombia3
- Herbal Brands, Inc. Delaware, United States3
- Herbal Brands, Ltd. London, United Kingdom3
- NS Herbal Brands International, Inc. British Columbia, Canada3
- NS US Holdings, Inc. Delaware, United States3
- Nordschwan Holdings, Inc. British Columbia, Canada3
- Northern Swan Deutschland Holdings, Inc. British Columbia, Canada3
- Northern Swan Europe, Inc. British Columbia, Canada3
- Northern Swan International, Inc. (“NSI”) British Columbia, Canada3
- Northern Swan Management, Inc. British Columbia, Canada3
- Northern Swan Portugal Holdings, Inc. British Columbia, Canada3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Apr 26, 20248-K Listing notice or transfer; Regulation FD disclosure23
- Apr 17, 20248-K Ended a material agreement24
- Apr 1, 20248-K Results of operations25
- Mar 27, 20248-K Entered a material agreement; Completed an acquisition or sale26
- Feb 1, 20248-K Entered a material agreement27
- Dec 20, 20238-K Entered a material agreement28
- Nov 9, 20238-K Results of operations29
- Oct 23, 20238-K Entered a material agreement30
- Aug 24, 20238-K Change to shareholders' rights; Regulation FD disclosure31
- Aug 14, 20238-K Results of operations32
- Jul 5, 20238-K Entered a material agreement; Completed an acquisition or sale33
- Jun 2, 20238-K Executive or director change; Shareholder vote34
- Jul 6, 2022New chief executive Andres Fajardo becomes CEO11
- Dec 18, 2020New chief executive Kyle Detwiler becomes CEO12
Calendar
When it reported results
- Apr 1, 2024Reported quarterly or annual results25
- Nov 9, 2023Reported quarterly or annual results29
- Aug 14, 2023Reported quarterly or annual results32
- May 11, 2023Reported quarterly or annual results35
- Mar 30, 2023Reported quarterly or annual results36
- Nov 9, 2022Reported quarterly or annual results37
- Aug 11, 2022Reported quarterly or annual results38
- May 12, 2022Reported quarterly or annual results39
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
180 filings to the SEC since October 2021: 3 annual reports, 7 quarterly reports, 33 major events, 53 insider forms, 10 large holders, 74 other. The latest 20:
- May 21, 20243 OWNERSHIP DOCUMENT EDGAR
- May 21, 2024SC 13D/A EDGAR
- May 16, 202415-12G EDGAR
- May 15, 2024SC 13D EDGAR
- May 8, 2024EFFECT EDGAR
- May 6, 2024S-8 POS REGISTRATION STATEMENT EDGAR
- May 6, 2024S-8 POS REGISTRATION STATEMENT EDGAR
- May 6, 2024S-8 POS REGISTRATION STATEMENT EDGAR
- May 6, 2024POS AM POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1 EDGAR
- May 6, 202425 EDGAR
- Apr 26, 20248-K CURRENT REPORT EDGAR
- Apr 22, 2024EFFECT EDGAR
- Apr 19, 2024AW AMENDMENT WITHDRAWAL EDGAR
- Apr 17, 20248-K EDGAR
- Apr 16, 2024POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 EDGAR
- Apr 15, 2024S-3/A S-3 EDGAR
- Apr 1, 202410-K EDGAR
- Apr 1, 20248-K EDGAR
- Mar 27, 2024424B3 EDGAR
- Mar 27, 20248-K EDGAR
The 180 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
31 open-market trades by officers, directors and large owners since October 2021: 0 buys and 31 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Mar 8, 2024 | Hague Henry R IIIChief Financial Officer | Sale | 170 | $3.31 | $563 | Form 4 |
| Feb 27, 2024 | Hague Henry R IIIChief Financial Officer | Sale | 411 | $3.95 | $1.6K | Form 4 |
| Jan 19, 2024 | Wilches JulianChief Regulatory Officer | Sale | 131 | $2.88 | $377 | Form 4 |
| Jan 19, 2024 | Fajardo AndresChief Executive Officer | Sale | 1,561 | $2.88 | $4.5K | Form 4 |
| Dec 20, 2023 | Wilches JulianChief Regulatory Officer | Sale | 135 | $2.04 | $275 | Form 4 |
| Dec 20, 2023 | Wilches JulianChief Regulatory Officer | Sale | 135 | $2.04 | $275 | Form 4 |
| Dec 20, 2023 | Fajardo AndresChief Executive Officer | Sale | 177 | $2.04 | $361 | Form 4 |
| Dec 20, 2023 | Fajardo AndresChief Executive Officer | Sale | 177 | $2.04 | $361 | Form 4 |
| Jul 18, 2023 | Hague Henry R IIIChief Financial Officer | Sale | 1,560 | $0.22 | $343 | Form 4 |
| Jul 18, 2023 | Wilches JulianChief Regulatory Officer | Sale | 813 | $0.22 | $179 | Form 4 |
| Jul 18, 2023 | Fajardo AndresChief Executive Officer | Sale | 2,938 | $0.22 | $646 | Form 4 |
| Jun 29, 2023 | Muecke WilliamDirector | Sale | 251 | $0.21 | $53 | Form 4 |
| Jun 29, 2023 | Julien Gary MDirector | Sale | 251 | $0.21 | $53 | Form 4 |
| Mar 3, 2023 | Hague Henry R IIIChief Financial Officer | Sale | 5,678 | $0.37 | $2.1K | Form 4 |
| Feb 24, 2023 | Hague Henry R IIIChief Financial Officer | Sale | 9,018 | $0.42 | $3.8K | Form 4 |
| Feb 22, 2023 | Hague Henry R IIIChief Financial Officer | Sale | 9,728 | $0.44 | $4.3K | Form 4 |
| Jan 17, 2023 | Wilches JulianChief Regulatory Officer | Sale | 4,557 | $0.40 | $1.8K | Form 4 |
| Jan 17, 2023 | Fajardo AndresChief Executive Officer | Sale | 57,669 | $0.40 | $23.1K | Form 4 |
| Dec 20, 2022 | Wilches JulianChief Regulatory Officer | Sale | 3,829 | $0.34 | $1.3K | Form 4 |
| Dec 20, 2022 | Fajardo AndresChief Executive Officer | Sale | 5,133 | $0.34 | $1.7K | Form 4 |
All 31 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Investimentos Fundo De Investimento Multimercado Credito Privado Investimento No Exterior BcmSC 13D/A, 2 filings May 15, 2024 to May 21, 202440
- FARALLON CAPITAL MANAGEMENT, L.L.C.SC 13G/A, 3 filings Feb 14, 2022 to Jan 23, 202441
- Kyle DetwilerSC 13D/A, 1 filing May 23, 202342
- Schultze Special Purpose Acquisition Sponsor, LLCSC 13D/A, 2 filings Feb 7, 2022 to Apr 3, 202343
- ETF MANAGERS GROUP, LLCSC 13G/A, 2 filings Nov 16, 2021 to Feb 14, 202244
SEC filer profile
How Clever Leaves Holdings Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARClever Leaves Holdings Inc.1
- CIK0001819615
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inBritish Columbia, Canada1
- Fiscal year endsDecember 311
- Industry code (SIC)2834 Pharmaceutical Preparations1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business addressBodega 19-B Parque Industrial Tibitoc Ph, Tocancipa - Cundinamarca, F8 2510171
- Phone561-634-74301
- Shares outstanding1,754,795 as of Mar 19, 20245
- Public float$11.9M as of Jun 30, 20235
- On EDGAR sinceAug 6, 20201
- Filings315 in all: 4 (69), 424B3 (45), 8-K (43), 425 (37), 3 (13), EFFECT (12), 10-Q (9), CORRESP (8)1
All 36 form types
POS AM (8), UPLOAD (8), SC 13G/A (6), S-8 POS (5), 10-K (4), 4/A (4), DEFA14A (4), S-4/A (4), SC 13D/A (4), 424B5 (3), DEF 14A (3), SC 13D (3), 3/A (2), 8-A12B (2), 8-K/A (2), S-1 (2), S-8 (2), SC 13G (2), SEC STAFF LETTER (2), 10-K/A (1), 15-12G (1), 25 (1), AW (1), CERT (1), DRS (1), S-3 (1), S-3/A (1), S-4 (1)
- Latest filingsAnnual report (10-K) Apr 1, 2024
Quarterly report (10-Q) Nov 9, 2023
Proxy statement (DEF 14A) Apr 18, 2023
Latest 8-K (8-K) Apr 26, 2024
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARAndres Fajardo, President
- 14
- 15SEC EDGARAmit Pandey, Chief financial officer
- 16
- 17SEC EDGARGeorge J. Schultze, Board member
- 18SEC EDGARWilliam Muecke, Board member
- 19SEC EDGARElisabeth H. Demarse, Board member
- 20SEC EDGAREtienne H. Deffarges, Board member
- 21SEC EDGARGary M. Julien, Board member
- 22SEC EDGARDavid Kastin, General counsel
- 23
- 24SEC EDGAREnded a material agreement
- 25SEC EDGARResults of operations
- 26
- 27SEC EDGAREntered a material agreement
- 28SEC EDGAREntered a material agreement
- 29SEC EDGARResults of operations
- 30SEC EDGAREntered a material agreement
- 31
- 32SEC EDGARResults of operations
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44